A Trial to Assess a Co-formulation of an Insulin Analog and Pramlintide in Subjects With Type 1 Diabetes Mellitus

NCT03916640 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 1 Diabetes Mellitus

Interventions

DRUG: ADO09 formulation
DRUG: Placebo
DRUG: Symlin®
DRUG: Humulin®
DRUG: Humalog®

Sponsor

Adocia